Literature DB >> 15034258

Neuregulin: an activity-dependent synaptic modulator at the neuromuscular junction.

Jeffrey A Loeb1.   

Abstract

Synaptic activity in the form of neurotransmitter release and postsynaptic depolarization is a prime motive force that guides synaptic development throughout the nervous system. The molecular basis of how synaptic activity is converted into structural changes that build and maintain synapses is a key question that has recently become focused on regulatory factors that act on tyrosine kinase receptors on both sides of the synaptic interface. The neuregulins are such a family of growth and differentiation factors that exist as both membrane-bound and soluble forms through alternatively splicing. Neuregulin functions to promote the local expression of acetylcholine receptors at neuromuscular synapses and therefore has the potential to strengthen specific synaptic connections. Recent evidence suggests that synaptic activity at the neuromuscular junction is coupled to presynaptic neuregulin release through an indirect mechanism acting through the postsynaptic expression of neurotrophic factors. At early stages of development, this could potentiate the stability of more active synapses. Later in development, heparin-binding forms of neuregulin accumulate to high levels in the synaptic basal lamina through the developmentally programmed expression of heparan sulfate proteoglycans, thus providing a sustained source of neuregulin to the most active synapses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15034258     DOI: 10.1023/B:NEUR.0000020640.84708.35

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  8 in total

1.  Activity dependent localization of synaptic NMDA receptors in spinal neurons.

Authors:  Kenneth M Rosen; Abhay Moghekar; Richard J O'Brien
Journal:  Mol Cell Neurosci       Date:  2006-12-29       Impact factor: 4.314

2.  Cell type-specific requirements for heparan sulfate biosynthesis at the Drosophila neuromuscular junction: effects on synapse function, membrane trafficking, and mitochondrial localization.

Authors:  Yi Ren; Catherine A Kirkpatrick; Joel M Rawson; Mu Sun; Scott B Selleck
Journal:  J Neurosci       Date:  2009-07-01       Impact factor: 6.167

3.  Neuregulin1 fine-tunes pre-, post-, and perisynaptic neuromuscular junction development.

Authors:  Jiajing Wang; Fei Song; Jeffrey A Loeb
Journal:  Dev Dyn       Date:  2017-03-20       Impact factor: 3.780

4.  Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.

Authors:  Guillem Mòdol-Caballero; Mireia Herrando-Grabulosa; Belén García-Lareu; Sergi Verdés; Rubén López-Vales; Gemma Pagès; Miguel Chillón; Xavier Navarro; Assumpció Bosch
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

5.  Rapid axoglial signaling mediated by neuregulin and neurotrophic factors.

Authors:  Raymond M Esper; Jeffrey A Loeb
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

6.  Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.

Authors:  Yuji Takahashi; Akiko Uchino; Ayako Shioya; Terunori Sano; Chihiro Matsumoto; Yurika Numata-Uematsu; Seiichi Nagano; Toshiyuki Araki; Shigeo Murayama; Yuko Saito
Journal:  Neuropathology       Date:  2019-05-24       Impact factor: 1.906

7.  Completion of neuronal remodeling prompts myelination along developing motor axon branches.

Authors:  Thomas Misgeld; Monika S Brill; Mengzhe Wang; Tatjana Kleele; Yan Xiao; Gabriela Plucinska; Petros Avramopoulos; Stefan Engelhardt; Markus H Schwab; Matthias Kneussel; Tim Czopka; Diane L Sherman; Peter J Brophy
Journal:  J Cell Biol       Date:  2021-04-05       Impact factor: 10.539

8.  Adenosine Receptors in Developing and Adult Mouse Neuromuscular Junctions and Functional Links With Other Metabotropic Receptor Pathways.

Authors:  Josep Tomàs; Neus Garcia; Maria A Lanuza; Manel M Santafé; Marta Tomàs; Laura Nadal; Erica Hurtado; Anna Simó-Ollé; Víctor Cilleros-Mañé; Laia Just-Borràs
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.